World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
74
Citations
19895
World Ranking
4674
National Ranking
1472

Peter P. Fu publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Peter P. Fu sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 423 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Peter P. Fu D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peter P. Fu sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 74 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Peter P. Fu is affiliated with the United States Food and Drug Administration in the United States. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant contributions distributed across related subfields including molecular biology, pharmacology, ecology, evolution, behavior and systematics, emergency medicine, and biomedical engineering.

The scientist's work concentrates on several main topics, notably plant toxicity and pharmacological properties, drug-induced hepatotoxicity and protection, botanical research and chemistry, poisoning and overdose treatments, as well as advanced biosensing and bioanalysis techniques. Specific attention is given to the detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids, a group of toxic compounds found in certain herbal medicines and dietary supplements.

Peter P. Fu has published extensively in several academic venues. The most frequent publication platforms include:

  • Journal of Food and Drug Analysis
  • Journal of Environmental Science and Health Part C
  • Chemical Research in Toxicology
  • The FASEB Journal
  • arXiv (Cornell University)

The author's recent notable publications include:

  • "Pyrrolizidine alkaloids - Tumorigenic components in Chinese herbal medicines and dietary supplements", 2020, Journal of Food and Drug Analysis
  • "Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China", 2020, Acta Pharmacologica Sinica
  • "Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements", 2020, Journal of Food and Drug Analysis
  • "Comprehensive investigation and risk study on pyrrolizidine alkaloid contamination in Chinese retail honey", 2020, Environmental Pollution
  • "Mutational Signature Analysis Reveals Widespread Contribution of Pyrrolizidine Alkaloid Exposure to Human Liver Cancer", 2021, Hepatology

Collaborations are an important aspect of Peter P. Fu's research. Frequent coauthors include:

  • Ge Lin
  • Qingsu Xia
  • Yisheng He
  • Jiang Ma
  • Lin Zhu

Overall, Peter P. Fu's scientific contributions emphasize molecular and pharmacological studies on plant-derived toxic compounds, with a notable focus on pyrrolizidine alkaloids and their effects on human health through hepatotoxicity and tumorigenicity research. Their collaborative work and publications contribute to understanding the risks associated with certain herbal medicines and dietary supplements from a biochemical and toxicological perspective.

Best Publications

  • Mechanisms of nanotoxicity: generation of reactive oxygen species.

    Peter P. Fu;Qingsu Xia;Huey-Min Hwang;Paresh C. Ray

  • Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs

    Paresh Chandra Ray;Hongtao Yu;Peter P. Fu

  • Pyrrolizidine alkaloids--genotoxicity, metabolism enzymes, metabolic activation, and mechanisms.

    Peter P. Fu;Qingsu Xia;Ge Lin;Ming W. Chou

  • The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials.

    Jun Jie Yin;Fang Lao;Peter P. Fu;Wayne G. Wamer

  • Photomutagenicity of 16 polycyclic aromatic hydrocarbons from the US EPA priority pollutant list.

    Jian Yan;Lei Wang;Peter P Fu;Hongtao Yu

  • Dehydrogenation of polycyclic hydroaromatic compounds

    Peter P. Fu;Ronald G. Harvey

  • Initial Oxidation Products in the Metabolism of Pyrene, Anthracene, Fluorene, and Dibenzothiophene by the White Rot Fungus Pleurotus ostreatus.

    L Bezalel;Y Hadar;P P Fu;J P Freeman

  • Phototoxicity of nano titanium dioxides in HaCaT keratinocytes--generation of reactive oxygen species and cell damage.

    Jun-Jie Yin;Jun Liu;Marilyn Ehrenshaft;Joan E. Roberts

  • Characterization, identification of ambient air and road dust polycyclic aromatic hydrocarbons in central Taiwan, Taichung

    Guor-Cheng Fang;Cheng-Nan Chang;Yuh-Shen Wu;Peter Pi-Cheng Fu

  • Phototoxicity and environmental transformation of polycyclic aromatic hydrocarbons (PAHs)-light-induced reactive oxygen species, lipid peroxidation, and DNA damage.

    Peter P. Fu;Qingsu Xia;Xin Sun;Hongtao Yu

  • Metabolism of nitro-polycyclic aromatic hydrocarbons.

    Peter P. Fu

  • Degradation of Benzo[a]pyrene by Mycobacterium vanbaalenii PYR-1

    Joanna D. Moody;James P. Freeman;Peter P. Fu;Carl E. Cerniglia

  • Metabolism of phenanthrene by the white rot fungus Pleurotus ostreatus.

    L Bezalel;Y Hadar;P P Fu;J P Freeman

  • Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay.

    Peter G. Wislocki;Edward S. Bagan;Anthony Y.H. Lu;Kenneth L. Dooley

  • Characterization of particulate, metallic elements of TSP, PM2.5 and PM2.5-10 aerosols at a farm sampling site in Taiwan, Taichung

    Guor-Cheng Fang;Cheng-Nan Chang;Chia-Chium Chu;Yuh-Shen Wu

  • Metabolic Activation of Pyrrolizidine Alkaloids: Insights into the Structural and Enzymatic Basis

    Jianqing Ruan;Mengbi Yang;Peter Fu;Yang Ye;Yang Ye

  • Theranostic nanomedicine for cancer detection and treatment.

    Zhen Fan;Peter P. Fu;Hongtao Yu;Paresh C. Ray

  • Enzyme-like activity of nanomaterials.

    Weiwei He;Wayne Wamer;Qingsu Xia;Jun-jie Yin

  • Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.

    Jun Jie Yin;Fang Lao;Jie Meng;Peter P. Fu

  • Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma

    Badri G. Modi;Jason Neustadter;Elisa Binda;Elisa Binda;Julia Lewis

  • Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo.

    Ya-Chen Yang;Jian Yan;Daniel R. Doerge;Po-Cheun Chan

Frequent Co-Authors

Ge Lin
Ge Lin Chinese University of Hong Kong
Robert H. Heflich
Robert H. Heflich United States Food and Drug Administration
Jun-Jie Yin
Jun-Jie Yin US Food and Drug Administration
Guor-Cheng Fang
Guor-Cheng Fang Hungkuang University
Frederick A. Beland
Frederick A. Beland National Center for Toxicological Research
Ronald G. Harvey
Ronald G. Harvey University of Chicago
Carl E. Cerniglia
Carl E. Cerniglia United States Food and Drug Administration
Daniel R. Doerge
Daniel R. Doerge United States Food and Drug Administration
Lei Guo
Lei Guo National Center for Toxicological Research
Paresh Chandra Ray
Paresh Chandra Ray Jackson State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students pursuing Chemistry in the USA often explore diverse career paths that overlap with other fields, including pharmaceutical and legal sectors. For those interested in entry-level education, an accredited online criminal justice associate degree offers flexibility and foundational knowledge relevant to regulatory aspects in chemical industries.

Another related pathway is becoming a paralegal, where understanding chemistry can aid in cases involving patent law or environmental regulations. If you’re considering this route, it's helpful to know about paralegal salary expectations, which vary based on specialization and location.

For a more chemistry-intensive career, pharmaceutical sales offer a practical application of chemical knowledge. Exploring how much do pharmaceutical sales reps make can provide insight into the rewards of blending science with business skills.

Finally, becoming a pharmacist is one of the most direct ways to leverage a Chemistry background professionally. However, it’s important to consider is it hard to become a pharmacist, as it requires rigorous education and licensing but can lead to a rewarding and stable career.

Best Scientists Citing Peter P. Fu

Trending Scientists

Recently Published Articles